![Sheri Dodd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sheri Dodd
Directeur Général chez
TACTILE SYSTEMS TECHNOLOGY, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Sheri L.
Dodd is Chief Executive Officer & Director at Tactile Systems Technology, Inc. since 2024.
Former roles include Vice President-Health Economics & Reimbursement at Johnson & Johnson from 1997 to 2010, Project Manager at World Health Organization (United States) from 1988 to 1993, VP & GM-Medtronic Care Management Services at Medtronic Plc from 2018 to 2022, and President at Medtronic Canada ULC.
Education includes graduate degrees from London School of Hygiene & Tropical Medicine and London School of Economics & Political Science, and an undergraduate degree from The College of Idaho, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/03/2026 | 79 911 ( 0,35% ) | 2 M $ | 31/05/2026 |
Postes actifs de Sheri Dodd
| Sociétés | Poste | Début |
|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY, INC. | Directeur Général | 01/07/2024 |
Anciens postes connus de Sheri Dodd
| Sociétés | Poste | Fin |
|---|---|---|
| MEDTRONIC PLC | Corporate Officer/Principal | 01/11/2022 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/03/2010 |
World Health Organization (United States)
 World Health Organization (United States) Medical/Nursing ServicesHealth Services The World Health Organization (United States) provides informative and advocacy-oriented content focused on women's health and related medical topics. The private company is based in Washington, DC. Key areas of emphasis include FDA warnings on asthma drugs, scientific inquiry into HPV vaccine safety, and updates on vaccine approvals such as the 2009 H1N1 influenza vaccine and expanded indications for Merck’s Gardasil vaccine to include women up to age 45 and young men for genital warts prevention. The organization covers a broad range of health issues including cancer, HPV, vaccination policies, and drug safety, promoting transparency, regulatory awareness, and active public engagement in health matters. | Corporate Officer/Principal | 01/09/1993 |
Medtronic Canada ULC
 Medtronic Canada ULC Medical SpecialtiesHealth Technology Manufactures medical devices | President | - |
Formation de Sheri Dodd
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Tactile Systems Technology, Inc.
 Tactile Systems Technology, Inc. Medical SpecialtiesHealth Technology Develops and markets medical devices | Health Technology |
London School of Hygiene & Tropical Medicine
 London School of Hygiene & Tropical Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Canada ULC
Medtronic Canada ULC Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
The College of Idaho, Inc.
 The College of Idaho, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Plc
 Medtronic Plc Medical SpecialtiesHealth Technology Provides medical technology services | Health Technology |
World Health Organization (United States)
World Health Organization (United States) Medical/Nursing ServicesHealth Services The World Health Organization (United States) provides informative and advocacy-oriented content focused on women's health and related medical topics. The private company is based in Washington, DC. Key areas of emphasis include FDA warnings on asthma drugs, scientific inquiry into HPV vaccine safety, and updates on vaccine approvals such as the 2009 H1N1 influenza vaccine and expanded indications for Merck’s Gardasil vaccine to include women up to age 45 and young men for genital warts prevention. The organization covers a broad range of health issues including cancer, HPV, vaccination policies, and drug safety, promoting transparency, regulatory awareness, and active public engagement in health matters. | Health Services |
